Vascular approach to gastroduodenal ulceration : New studies with endothelins and VEGF

• Published in: Digestive diseases and sciences Vol. 43; no. 9; pp. 40S - 45S
• Main Authors: SZABO, S, VINCZE, A, SANDOR, Z, JADUS, M, GOMBOS, Z, PEDRAM, A, LEVIN, E, HAGAR, J, IAQUINTO, G
• Format: Conference Proceeding Journal Article
• Language: English
• Published: Heidelberg Springer 01.09.1998
• Subjects: Animals; Biological and medical sciences; Capillary Permeability - drug effects; Endothelial Growth Factors - metabolism; Endothelins - metabolism; Gastroenterology. Liver. Pancreas. Abdomen; Humans; Lymphokines - metabolism; Medical sciences; Other diseases. Semiology; Peptic Ulcer - diagnosis; Peptic Ulcer - drug therapy; Peptic Ulcer - metabolism; Stomach. Duodenum. Small intestine. Colon. Rectum. Anus; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factors; Human; Endothelin; Pathophysiology; Peptide hormone; Permeability factor; Review; Experimental study; Gastroduodenal; Vascular endothelium growth factor; Digestive diseases; Intestinal disease; Vasoconstrictor agent; Ulcer; Mechanism of action; Gastric disease
• ISSN: 0163-2116; 1573-2568

Endothelins (ET) and VEGF/VPF (vascular endothelial growth factor/vascular permeability factor) are products mainly of endothelial cells, which are also regulated via autocrine and paracrine pathways by these peptides. As a follow-up to our focus on vascular factors in ulcer pathogenesis and healing, we review here our recent studies with ET-1 and VEGF/VPF in animal models and human subjects. Our new results demonstrated a rapid and time-dependent release of ET-1 into the systemic circulation after intragastric administration of ethanol or HCI in rats, and ethanol in humans. The ET-1 release preceded the development of hemorrhagic erosions in both species and might be used as a diagnostic tool to noninvasively quantify acute gastric mucosal lesions. The development of solitary duodenal ulcers in the rat was preceded only by an organ- (involving only the duodenum and not the stomach) and molecule-specific (induced only by cysteamine and not by the nonulcerogenic analog ethanolamine) rapid local release of ET-1. The severity of cysteamine-induced duodenal ulcers was dose-dependently decreased by pretreatment with ET-1 antibodies or antagonist bosentan. A single intragastric dose of VEGF/VPF resulted in gastroprotection against ethanol, while daily intragastric treatment with the peptide for three weeks stimulated angiogenesis in the base of cysteamine-induced duodenal ulcers and accelerated ulcer healing. Thus, modulation of vascular factors seems to be sufficient for both acute gastroprotection and chronic duodenal ulcer healing.